HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease.
Andrikovics H, Meggyesi N, Szilvasi A, Tamaska J, Halm G, Lueff S, Nahajevszky S, Egyed M, Varkonyi J, Mikala G, Sipos A, Kalasz L, Masszi T, Tordai A.
Andrikovics H, et al. Among authors: tordai a.
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):929-34. doi: 10.1158/1055-9965.EPI-08-0359. Epub 2009 Mar 3.
Cancer Epidemiol Biomarkers Prev. 2009.
PMID: 19258483